India's Affordable Weight-Loss Pills Set to Shake Up Global Obesity Battle

India is on the verge of a major change in the way people can access weight-loss medicines. The patent for semaglutide, the main ingredient in popular drugs like Wegovy and Ozempic, is expiring in India this week. This is a big deal because it means Indian pharmaceutical companies can now make their own versions of the drug, called generics, which are much cheaper than the original brands. Experts believe this could cut the price of these medicines by more than half, making them available to many more people in India and possibly in other countries as well.

Semaglutide was first created to help people with diabetes, but it has become famous for helping people lose weight. It works by making people feel full sooner and for longer, so they eat less. Until now, only wealthy people could afford these injections, which cost between 8,800 and 16,000 rupees a month. With the patent ending, the price could drop to as low as 3,000 rupees a month. This is expected to cause a rush of new brands entering the market, just like what happened with another diabetes drug, sitagliptin, when its patent expired. India's pharmaceutical industry is already very strong in making generic medicines, and this new opportunity could make it even bigger.

India has one of the largest populations of people with diabetes and obesity in the world. More than 77 million Indians have type-2 diabetes, and many adults are overweight due to unhealthy diets and not enough exercise. Cheaper weight-loss drugs could help doctors treat more patients, not just for weight loss but also for heart problems, joint pain, and sleep issues. However, doctors warn that these drugs are not magic solutions. They can have side effects like nausea and stomach problems, and they work best when combined with a healthy diet and exercise. Some people expect to lose a lot of weight very quickly, but doctors say slow and steady weight loss is healthier.

India is known for making affordable medicines for the world. It supplies generic drugs to over 200 countries and is called the 'pharmacy of the world. ' If Indian companies start exporting cheap weight-loss drugs, it could help millions of people in other countries too. However, there are concerns about safety and misuse. Some people might try to get the drugs without a doctor's advice, or use them in the wrong way. The government has warned companies not to advertise these drugs directly to consumers and to make sure they are only used under medical supervision.

In the coming months, India will have to balance making these drugs affordable with making sure they are used safely. Doctors say patients should try to improve their diet and exercise before starting these medicines. Even then, they should be closely watched by a doctor. If everything goes well, millions of people could benefit from cheaper weight-loss drugs, both in India and around the world. But it is important to remember that medicine is just one part of staying healthy. Eating well, being active, and following a doctor's advice are still very important.